2025-12-19 - Analysis Report
Okay, here's a breakdown of Procter & Gamble (PG) stock based on the data provided.

**0) Report Structure**

*   **Simple Numbers:** I'll present the raw data points.
*   **Simple Analysis:** I'll offer basic interpretations of the numbers and trends.

**1) Return Rate Comparison**

*   **Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation.
*   **PG Cumulative Return:** 27.06%
*   **VOO (S&P 500) Cumulative Return:** 99.09%
*   **Divergence:** -73.0 (Relative Divergence: 7.0)
    *   The divergence indicates that PG has significantly underperformed the S&P 500 over the period for which cumulative returns were calculated. The relative divergence of 7.0 suggests this underperformance is near the lower end of its historical range, meaning it has been worse at times.

**Alpha, Beta Analysis & Interpretation:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 21.0% | 7.9% | -8.0% | 0.0 | 215.0 |
| 2016-2018  | 9.0% | 67.3% | -6.0% | 0.1 | 215.1 |
| 2017-2019  | 24.0% | 70.4% | 2.0% | 0.3 | 292.3 |
| 2018-2020  | 27.0% | 78.8% | 4.0% | 0.4 | 325.7 |
| 2019-2021  | 41.0% | 78.8% | -5.0% | 0.5 | 382.9 |
| 2020-2022  | 13.0% | 79.4% | 13.0% | 0.6 | 354.7 |
| 2021-2023  | 26.0% | 79.4% | 24.0% | 0.4 | 343.0 |
| 2022-2024  | 9.0% | 79.4% | -12.0% | 0.4 | 392.4 |
| 2023-2025  | -17.0% | 80.1% | -81.0% | 0.1 | 340.6 |

*   **CAGR (Compound Annual Growth Rate):** Shows the average annual growth over the period.  CAGR is inconsistent, declining steeply most recently.
*   **MDD (Maximum Drawdown):**  Indicates the largest peak-to-trough decline during the period. MDD has generally been quite high over the later periods, indicating substantial volatility.
*   **Alpha:** Measures the investment's performance relative to a benchmark (presumably the S&P 500). Negative alpha means underperformance, while positive alpha means outperformance. PG had relatively good alpha until recently but plummeted in the 2023-2025 period.
*   **Beta:** Measures the investment's volatility relative to the market. A beta of 1 indicates the investment moves in line with the market.  PG's beta is consistently low and stable, indicating low volatility compared to the S&P 500.
*   **Cap(B) (Capitalization in Billions):** Shows the company's market capitalization during the given periods.

**2) Recent Stock Price Fluctuations**

*   **Close:** 145.52
*   **Last-market:**  Price: 145.52, Previous Close: 147.81, Change: -1.55
*   **5-day SMA:** 145.30
*   **20-day SMA:** 145.09
*   **60-day SMA:** 148.19

**Analysis:** The stock price closed slightly lower than its previous close. The 5-day and 20-day SMAs are very close, suggesting a period of price consolidation. The 60-day SMA is higher than both the recent closing price and the shorter-term SMAs, potentially indicating that the stock is currently trading below its longer-term trend.

**3) Index Indicators**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 44.40
*   **PPO (Percentage Price Oscillator):** 0.36
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 5.8 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** 2.2%

**Analysis:**

*   **MRI:** A reading of 0.7 suggests a medium level of risk for investment.
*   **RSI:** An RSI of 44.40 indicates that the stock is neither overbought nor oversold. It's in a neutral zone.
*   **PPO:** A positive PPO suggests a bullish short-term trend relative to a longer-term trend.
*   **Hybrid Signal:** The hybrid signal recommends buying with all available cash, suggesting the system views PG as a relatively safe investment at this time (based on an MRI of 0.90 used in its calculation, which differs from the overall MRI).
*   **Divergence Change:** The recent increase in relative divergence indicates some short-term positive momentum compared to the S&P 500.
*   **Expected Return:** The expected return of 2.2% suggests a modest potential gain from holding the stock long-term.

**4) Recent News & Significant Events (Yahoo Finance)**

*   **JPMorgan Cuts Price Target:** Indicates some potential concerns from analysts.
*   **Stock Sinks As Market Gains:** Shows relative weakness compared to the overall market.
*   **Jim Cramer's Favorite:** Positive sentiment from a well-known commentator.
*   **Analyst Downgrade:** Negative signal.
*   **Buy PG vs. Colgate-Palmolive?:** A comparative analysis suggests relative appeal compared to a specific competitor.
*   **2-Year Low:** Suggests the stock has been underperforming recently.

**Analysis:** The news headlines paint a mixed picture. Analyst downgrades and price target cuts are negative, while mentions as a "favorite stock" are positive. The repeated theme of underperformance relative to the market is a concern.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (1.92, ~Buy)
*   **Opinions:** 22 Analysts
*   **Target Price:** Avg: 169.18 / High: 186.00 / Low: 148.00

**Analysis:** The analyst consensus is leaning towards "Buy," suggesting that analysts generally believe the stock is undervalued. The average target price of $169.18 indicates a potential upside from the current price of $145.52. However, the analyst opinions shown are mixed in the previous section.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-10-24 | 2.00 | 22.39 B$    |
| 2025-04-24 | 1.58 | 19.78 B$    |
| 2025-01-22 | 1.94 | 21.88 B$    |
| 2024-10-18 | 1.65 | 21.74 B$    |
| 2025-10-24 | 1.65 | 21.74 B$    |

**Analysis:**
Note that there is a duplicate entry for 2025-10-24, likely an error. The trend shows inconsistent EPS and Revenue figures. The latest quarter (2025-10-24) shows relatively strong EPS and revenue. However, a longer trend is required for more conclusive observations.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $22.39B   | 51.37%        |
| 2025-06-30   | $20.89B   | 49.11%        |
| 2025-03-31   | $19.78B   | 50.98%        |
| 2024-12-31   | $21.88B   | 52.39%        |
| 2024-09-30   | $21.74B   | 52.06%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-09-30   | $53.27B   | 8.92%    |
| 2025-06-30   | $52.01B   | 6.95%    |
| 2025-03-31   | $52.27B   | 7.21%    |
| 2024-12-31   | $51.17B   | 9.05%    |
| 2024-09-30   | $51.84B   | 7.64%    |

**Analysis:**
*   **Revenue:** Revenue has fluctuated over the past five quarters, with a recent increase in the last reported quarter.
*   **Profit Margin:** Profit margins are consistently high, indicating strong pricing power and efficient cost management.
*   **Equity:** Equity has generally been increasing, suggesting the company is retaining earnings and growing its asset base.
*   **ROE (Return on Equity):** ROE has fluctuated, indicating changes in profitability relative to shareholder equity.

**7) Comprehensive Analysis**

*   **Underperformance:** PG has significantly underperformed the S&P 500, and this underperformance seems to be near a historical low (relative divergence).
*   **Mixed Signals:** Analyst opinions are mixed, with downgrades and price target cuts balanced by some positive sentiment. The consensus is still leaning towards a "Buy" rating with a potential upside based on target prices.
*   **Recent Price Action:** The stock is currently trading below its 60-day moving average, suggesting possible short-term weakness. However, there has been some short-term positive momentum recently compared to the S&P 500.
*   **Earnings and Financials:** Earnings results are fluctuating, but revenue and profit margins remain robust. The company's equity continues to grow.
*   **Risk:** The MRI suggests a medium level of investment risk.

**Conclusion:**

PG presents a complex picture. It's a stable, dividend-paying company with strong brands and high profit margins. However, it has underperformed the broader market significantly, and recent news and analyst actions present mixed signals. While the Hybrid Signal recommends buying and the analyst consensus is positive, the underperformance and downgrades should be considered.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.